ALHC

SEC source: 0001209191-24-004788 · doc4.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,312,253

F1 · shares: Represents the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based restricted stock units ("RSUs"). The withholding of these shares occurred automatically upon the vesting of the RSUs, and as such, no investment decision was made by the Reporting Person in connection with this transaction.

SEC source: 0001628280-25-034806 · wk-form4a_1752268073.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,310,972

F1 · shares: Represents the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based restricted stock units ("RSUs"). The withholding of these shares occurred automatically upon the vesting of the RSUs, and as such, no investment decision was made by the Reporting Person in connection with this transaction.

SEC source: 0001209191-24-004691 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,853,008

F1 · shares: Represents bona fide gifts to family members.

SEC source: 0001209191-24-003056 · doc4.xml · nonDerivative · entry 1

Wagner Andreas P. · CIK 0002006326 · Chief People & Culture Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 155,763

F1 · kind: Represents 155,763 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company on the applicable vesting date.

SEC source: 0001209191-23-059572 · doc4.xml · nonDerivative · entry 1

Burzacchi Sebastian · CIK 0002002259 · COO - Mgmt Services Org

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,945

F1 · kind: Represents 125,945 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of December 6, 2024, 2025, 2026 and 2027, subject to the reporting person's continued service to the Company on the applicable vesting date.

SEC source: 0001209191-23-058801 · doc4.xml · nonDerivative · entry 1

MARGOLIS JEFFREY H · CIK 0001105688 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 417,133

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · ownership.nature: Represents securities held by the Margolis Family trust 12/23/98, of which Mr. Margolis is the trustee.

SEC source: 0001209191-23-057683 · doc4.xml · nonDerivative · entry 1

MARGOLIS JEFFREY H · CIK 0001105688 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 418,333

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · ownership.nature: Represents securities held by the Margolis Family trust 12/23/98, of which Mr. Margolis is the trustee.

SEC source: 0001209191-23-055440 · doc4.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,188,221

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

SEC source: 0001209191-23-053097 · doc4.xml · nonDerivative · entry 1

MARGOLIS JEFFREY H · CIK 0001105688 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 419,533

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $8.00 to $8.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by the Margolis Family trust 12/23/98, of which Mr. Margolis is the trustee.

SEC source: 0001209191-23-052350 · doc4.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 402,136

F1 · kind: Represents 340,136 restricted stock units ("RSUs"), each RSU representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001209191-23-049618 · doc4.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,193,119

F1 · kind: Represents 174,216 restricted stock units ("RSUs"), each RSU representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

SEC source: 0001209191-23-049616 · doc4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,834

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

SEC source: 0001209191-23-048812 · doc4.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 283,308

F1 · kind: Represents (i) 245,023 restricted stock units ("RSUs"), each RSU representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date, and (ii) 38,285 RSUs which vested immediately on the grant date, subject to forfeiture to the Company in the event of certain qualyfing terminations of employment, 100% if prior to the first anniversary of the grant date and 50% if after the first annivesary but prior to the second anniversary of the grant date.

SEC source: 0001209191-23-041829 · doc4.xml · nonDerivative · entry 1

Kimbro Melinda Michele · CIK 0001653953 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,439

F1 · kind: Represents 175,439 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company.

SEC source: 0001209191-23-028510 · doc4.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,859,008

F1 · kind: Reflects bona fide gifts to a charitable donor advised fund.

SEC source: 0001209191-23-028510 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,864,308

F1 · kind: Reflects bona fide gifts to a charitable donor advised fund.

SEC source: 0001209191-23-021894 · doc4.xml · nonDerivative · entry 2

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 709,376

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock. This transaction does not represent a discretionary trade by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.211 to $6.33. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-021890 · doc4.xml · nonDerivative · entry 1

Cross Richard A. · CIK 0001879095 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 393,460

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-021893 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,929,308

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-021894 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 712,666

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-021891 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,088,651

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-021892 · doc4.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,346,773

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-018986 · doc4.xml · nonDerivative · entry 1

Cross Richard A. · CIK 0001879095 · SVP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 395,170

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.93 to $6.74. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-018984 · doc4.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,936,486

F3 · shares: Represents bona fide gifts to family members.

SEC source: 0001209191-23-018984 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,938,886

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.93 to $6.74. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-018988 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 717,978

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.93 to $6.74. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-018987 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,091,937

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.93 to $6.74. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-018985 · doc4.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,381,279

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.93 to $6.74. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-017853 · doc4.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director · Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,018,903

SEC source: 0001209191-23-017850 · doc4.xml · nonDerivative · entry 1

MARGOLIS JEFFREY H · CIK 0001105688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,451

F1 · kind: Represents 21,802 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-23-017847 · doc4.xml · nonDerivative · entry 1

McCarthy Margaret M · CIK 0001485980 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,120

F1 · kind: Represents 21,802 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for five years (or, if earlier, until separation from service or a change of control of the Company).

SEC source: 0001209191-23-017844 · doc4.xml · nonDerivative · entry 1

CARELLA THOMAS J. · CIK 0001477767 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,478

F1 · kind: Represents 29,070 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-23-017845 · doc4.xml · nonDerivative · entry 1

KOSECOFF JACQUELINE B · CIK 0001209524 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,609

F1 · kind: Represents 29,070 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, until separation from service or a change of control of the Company).

SEC source: 0001209191-23-017851 · doc4.xml · nonDerivative · entry 1

BILNEY JODY L · CIK 0001185995 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,744

F1 · kind: Represents 29,070 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation from service (or, if earlier, until change of control of the Company).

SEC source: 0001209191-23-017848 · doc4.xml · nonDerivative · entry 1

JORDEN YON · CIK 0001189397 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,476

F1 · kind: Represents 21,802 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-23-017852 · doc4.xml · nonDerivative · entry 1

HODGSON DAVID C · CIK 0001193346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,716

F1 · kind: Represents 36,337 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company).

SEC source: 0001209191-23-017843 · doc4.xml · nonDerivative · entry 1

McClellan Mark B. · CIK 0001567006 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,177

F1 · kind: Represents 21,802 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.

SEC source: 0001209191-23-017846 · doc4.xml · nonDerivative · entry 1

Vorhoff Nicholas Robbert · CIK 0001794455 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,716

F1 · kind: Represents 36,337 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company).

SEC source: 0001209191-23-015676 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,958,892

F1 · kind: Represents bona fide gifts to family members.

SEC source: 0001209191-23-006991 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,106,101

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.41. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-004323 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 519,429

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0001209191-23-004325 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,116,101

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-004324 · doc4.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,723,100

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001209191-23-004073 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,965,692

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.31 to $12.67. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-003777 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,117,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.18. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-23-001934 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,126,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.03. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-062458 · doc4.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,970,692

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-062017 · doc4.xml · nonDerivative · entry 3

Maroney Dawn Christine · CIK 0001850397 · President, Markets

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,974,966

F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.07. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209191-22-059509 · doc4.xml · nonDerivative · entry 1

Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 520,529

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.41. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.

SEC source: 0001209191-22-059510 · doc4.xml · nonDerivative · entry 1

Kumar Dinesh M. · CIK 0001850439 · Chief Med & Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,127,226

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.82 to $13.43. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.